PT-141 | Bremelanotide Sexual Function

PT-141, also known as bremelanotide, is a peptide studied for sexual desire and sexual-function signaling in the brain. Unlike medications that primarily work through blood flow, PT-141 acts through melanocortin pathways in the nervous system, which is why researchers have examined it in both female and male sexual-function research.

In scientific terms, bremelanotide is a synthetic melanocortin receptor agonist derived from melanotan-related research. Its activity at central melanocortin receptors, particularly MC4R, has been studied in relation to sexual arousal and desire. PT-141 has human clinical research and an approved bremelanotide drug product exists for a specific indication, although research-product use should not be assumed equivalent to that approved product.

Product contents: Contains 15 mg total in 3 mL of liquid (5 mg/mL).

Explore the PT-141 research →